ViiV Healthcare’s long-acting HIV treatment Cabenuva achieved superior viral suppression [...]

The FDA has approved ViiV Healthcare’s Tivicay PD for children [...]

ViiV Healthcare’s long-acting injectable Cabenuva has demonstrated superior virologic outcomes [...]

ViiV Healthcare’s two-drug HIV regimen Dovato was non-inferior to the [...]

ViiV Healthcare has secured FDA Priority Review for its application [...]

Gilead Sciences has announced positive topline results from the Phase [...]

Cabotegravir and rilpivirine long-acting treatment proves highly effective and widely [...]